Literature DB >> 6818270

Lack of dissociation of prolactin responses to thyrotropin releasing hormone and metoclopramide in chronic alcoholic men.

D H Van Thiel, J S Gavaler, A Sanghvi.   

Abstract

Prolactin, growth hormone and thyroid stimulating hormone responses to thyrotropin releasing hormone (TRH) and metoclopramide were determined in 12 alcoholic men with biopsy proven liver disease and were compared to those of 8 age matched normal controls. All subjects were challenged with TRH (400 micrograms) and metoclopramide (10 mg) given as an intravenous bolus each on a separate day. Alcoholics had increased basal prolactin and growth hormone levels compared to controls. Alcoholics had a brisk and statistically significant (p less than 0.01) response for each of the 3 hormones studied in response to TRH. In contrast to the alcoholics, the controls did not demonstrate a growth hormone response to TRH. Moreover, the TSH response to TRH of the alcoholics was exaggerated (p less than 0.05) compared to that of the controls. In response to metoclopramide, alcoholics had a brisk prolactin response, failed to demonstrate a TSH response, and had a decline in growth hormone when compared to controls. These results for alcoholics with liver disease differ from those reported for individuals with renal failure while those for the controls are similar to previously reported normal responses. These data suggest that liver disease and renal disease must differ in terms of their patterns of hypothalamic-pituitary neuroregulation as documented by their differing pituitary hormone responses to TRH and metoclopramide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818270     DOI: 10.1007/BF03350515

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

1.  Recurrent psychosis associated with liver disease and elevated blood ammonia.

Authors:  L L HAVENS; C G CHILD
Journal:  N Engl J Med       Date:  1955-05-05       Impact factor: 91.245

2.  Treatment of hepatic coma and hepatorenal syndrome. Mechanism of action of L-dopa and aramine.

Authors:  J E Fischer; J H James
Journal:  Am J Surg       Date:  1972-02       Impact factor: 2.565

3.  False neurotransmitters and hepatic failure.

Authors:  J E Fischer; R J Baldessarini
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

4.  Abnormalities in the regulation of prolactin in patients with chronic renal failure.

Authors:  G Ramirez; W M O'Neill; H A Bloomer; W Jubiz
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

5.  Studies on the pathogenesis of uremia. Comparative determinations of glucuronic acid, indican, free and bound phenols in the serum, cerebrospinal fluid, and urine of renal diseases with and without uremia.

Authors:  D Müting
Journal:  Clin Chim Acta       Date:  1965-11       Impact factor: 3.786

6.  Dissociation of prolactin response to thyrotropin-releasing hormone and metoclopramide in chronic renal failure.

Authors:  D Leroith; G Danovitz; S Trestan; I M Spitz
Journal:  J Clin Endocrinol Metab       Date:  1979-12       Impact factor: 5.958

7.  Endocrinology and metabolism in uremia and dialysis: a clinical review.

Authors:  H A Feldman; I Singer
Journal:  Medicine (Baltimore)       Date:  1975-09       Impact factor: 1.889

8.  Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.

Authors:  M Uribe; A Farca; M A Márquez; G Garcĭa-Ramos; L Guevara
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

9.  Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.

Authors:  H Michel; M Solere; P Granier; G Cauvet; J P Bali; F Pons; H Bellet-Hermann
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

10.  Hyperprolactinemia in portal systemic encephalopathy.

Authors:  C J McClain; J P Kromhout; M K Elson; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

View more
  3 in total

1.  Thyroid and pituitary hormone responses to TRH in advanced nonalcoholic liver disease.

Authors:  D H Van Thiel; R Tarter; J S Gavaler; R R Schade; A Sanghvi
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

2.  Effect of ethanol infusion on the pituitary-testicular responsiveness to gonadotropin releasing hormone and thyrotropin releasing hormone in normal males and in chronic alcoholics presenting with hypogonadism.

Authors:  P Bertello; L Gurioli; R Faggiuolo; F Veglio; C Tamagnone; A Angeli
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

3.  Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy.

Authors:  A Masala; S Alagna; P P Rovasio; A Deplano; V Anania; L Chiandussi; M Langer
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.